ADAR1 Prevents R-loop Accumulation-Driven ATR Pathway Activation in Ovarian Cancer
Hanwei Cui(Shenzhen Metro (China)), Xiufeng Ye(Shenzhen Second People's Hospital), Yuteng Liang(Shenzhen Second People's Hospital), Jie Huang(Institute for Reproductive Health), Jianxin Guo(Army Medical University), Hai Yang(Universitätsklinikum Erlangen), Qian Yi(Southwest Medical University), Wenlan Liu(Capital Medical University), Qi Zeng(Army Medical University), Min Tian(Jiangnan University), Jian Han(National University Cancer Institute, Singapore), Zhiying Yu(Shenzhen Second People's Hospital), Weichao Sun(Guilin University of Technology)
Cited by 19
Related Papers
Chemoresistance in Pancreatic Cancer
|International Journal of Molecular Sciences|2019|617
Biological roles of RNA m5C modification and its implications in Cancer immunotherapy
|Biomarker Research|2022|235
Enhancement of methane production from cassava residues by biological pretreatment using a constructed microbial consortium
|Bioresource Technology|2011|203
Chimeric antigen receptor-engineered natural killer cells for cancer immunotherapy
|Journal of Hematology & Oncology|2020|172
RBFox2 Binds Nascent RNA to Globally Regulate Polycomb Complex 2 Targeting in Mammalian Genomes
|Molecular Cell|2016|100